Hubbry Logo
Spike-and-waveSpike-and-waveMain
Open search
Spike-and-wave
Community hub
Spike-and-wave
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Spike-and-wave
Spike-and-wave
Spike-and-wave
View on Wikipedia
from Wikipedia
EEG recording of generalized 3 Hz spike-and-wave discharges seen in a child during an absence seizure

Spike-and-wave is a pattern of the electroencephalogram (EEG) typically observed during epileptic seizures. A spike-and-wave discharge is a regular, symmetrical, generalized EEG pattern seen particularly during absence epilepsy, also known as ‘petit mal’ epilepsy.[1] The basic mechanisms underlying these patterns are complex and involve part of the cerebral cortex, the thalamocortical network, and intrinsic neuronal mechanisms.[2]

The first spike-and-wave pattern was recorded in the early twentieth century by Hans Berger. Many aspects of the pattern are still being researched and discovered, and still many aspects are uncertain. The spike-and-wave pattern is most commonly researched in absence epilepsy, but is common in several epilepsies such as Lennox–Gastaut syndrome (LGS) and Ohtahara syndrome. Antiepileptic drugs (AEDs) are commonly prescribed to treat epileptic seizures, and new ones are being discovered with fewer adverse effects. Today, most of the research is focused on the origin of the generalized bilateral spike-and-wave discharge. One proposal suggests that a thalamocortical (TC) loop is involved in the initiation spike-and-wave oscillations. Although there are several theories, the use of animal models has provided new insight on spike-and-wave discharge in humans.[3]

History

[edit]

History of generalized epilepsy with absence seizures are dated to the eighteenth century, however the inventor of the electroencephalogram (EEG), Hans Berger, recorded the first EEG of an absence seizure in the 1920s, which led the way for the general notion of spike-and-wave electrophysiology. His first recording of a human EEG was made in 1924 using a galvanometer, but his results were very crude and showed small, undefined oscillations. He continued to refine his technique and increase the sensitivity to the galvanometer, in which he accumulated many EEGs of individuals with and without a brain malfunction or disorder. Among those tested were patients with epilepsy, dementia, and brain tumors.[4] Hans Berger published his findings in 1933, however his results did not give a definitive characterization of the general EEG pattern seen during an epileptic seizure. In 1935, F.A. Gibbs, H. Davis, and W.G. Lennox provided a clear description of EEG spike-and-wave patterns during a petit mal epileptic seizure.[5] An intracellular recording performed by DA Pollen in 1964 revealed that the "spike" aspect of the phenomenon was associated with neuronal firing and the "wave" aspect was associated with hyperpolarization.[6]

Pathophysiology

[edit]
A drawing of the human brain showing the thalamus and cortex relative to other structures

The spike-and-wave pattern seen during an absence seizure is the result of a bilateral synchronous firing of neurons ranging from the neocortex (part of the cerebral cortex) to the thalamus, along the thalamocortical network.[2] The EEG “spike” of the spike-and-wave complex corresponds to the depolarization of the neuronal membrane potential, also called a paroxysmal depolarizing shift (PDS). The initial understanding behind the mechanism of the PDS was that it was caused by a very large EPSP (excitatory postsynaptic potential) in the absence of synaptic inhibition, which relayed the action potentials in the neurons by triggering activation of voltage-gated channels. The voltage-gated sodium channels cause transitory sodium current into the cell, which generates the action potential. The voltage-gated calcium channels also have some effect on the depolarization of the cell, but the effect is minimal compared to the sodium channels. However, the increasing concentration of intracellular calcium leads to greater activation of calcium-activated potassium channels. These calcium-activated potassium channels, along with the voltage-gated potassium channels, contribute to the repolarization and hyperpolarization of the membrane. In an epileptic seizure, there are periods of a sustained depolarization, which cause a train of action potentials followed by a repolarization and hyperpolarization phase. The train of action potentials constitutes the “spike” phase, and the repolarization and hyperpolarization constitute the “wave” phase.[7]

Although there is evidence for the generation of a large EPSP, many studies have shown that synaptic inhibition remains functional during the generation of these types of paroxysmal depolarizing shifts.[8][9] Also, it has been shown that a decrease in the inhibitory activity does not affect neocortical kindling.[10] Therefore, the theory that spike-and-wave activity is caused by a giant EPSP due to the decrease or the absence of IPSPs (inhibitory postsynaptic potentials) is not accepted as a general mechanism for epileptic activity. Many studies have shown that the inhibitory postsynaptic signaling is actually increased during these epileptic attacks.[9] The activation of postsynaptic GABAA receptors leads to an increase in the intracellular chloride concentration, which in non-epileptic situations would lead to an IPSP. However, in seizure-related depolarizing shifts, there is a substantial activation of postsynaptic GABAA receptors, which leads to an even larger concentration of intracellular chloride concentration. This change in ion concentration gradient causes the GABAA inhibitory current to surpass the reversal potential, leading to an efflux of the chloride ions. This leads to a decreased amplitude or even reversed polarity of the IPSPs.[7]

Metabotropic glutamate receptors (mGluRs) in the thalamocortical network have also shown to display some role in the generation of spike-and-wave discharges (SWDs) associated with absence epilepsy. The different subtypes of mGlu receptors have a modulatory role on either excitatory or inhibitory synaptic transmission. There are conflicting hypotheses for the function of the many mGlu receptors with regards to epileptic seizures, however the role of the mGlu4 receptor is undisputed in the generation of SWDs, shown in animal models.[11] In one study, knockout mice lacking mGlu4 receptors showed a disruption of glutamate and GABA release in the thalamocortical network and were resistant to absence seizures induced by low doses of pentylenetetrazole.[12] Another study showed that bilateral injection of a mGlu4 receptor antagonist into the nRT (thalamic reticular nucleus) of normal mice protected against pentylenetetrazole induced seizures.[12] Also, WAG/Rij rats show an increased expression of mGlu4 receptors in the nRT when compared to a control group of normal rats.[13] These studies show that an increase in the expression and/or activity of mGlu4 receptors is associated with spike-and-wave discharges seen in absence seizures. This link between mGlur4 receptors and SWDs has led to the search for a selective mGlu4 receptor antagonist (which will block these receptors) as a potential new drug for the treatment of absence epilepsy.[11]

Initiation factors

[edit]

The use of animal models, such as cats, for studying spike-and-wave discharges, has provided useful data for studying epilepsy in humans. One method of inducing a seizure in a cat is to inject penicillin into the cortical region of the brain. The spike-and-wave discharges seen in feline generalized penicillin epilepsy (FGPE) are very similar to the spike-and-wave discharges of a human absence seizure.[14] The use of rats has also been a common method for studying the spike-and-wave phenomenon. The Genetic Absence Epilepsy Rats from Strasbourg (GAERS) and the inbred Wistar Albino Glaxo rats from Rijswijk (WAG/Rij) are the two main strains of rats that have been used in studies. The rats from these two strains show spontaneously occurring absence seizures that consist of typical spike-and-wave activity seen on an EEG.[1] Rat genetic models have given data showing that the expression of absence seizures involves both the thalamic and cortical networks. In both models, electrophysiological data showed that spike-and-waves are initiated in the somatosensory cortex and then spread rapidly to the motor cortex and thalamic nuclei.[15][16] Using in vivo intracellular recordings, it was found in the GAERS that spike-and-wave are initiated in layer 5/6 neurons of the somatosensory cortex. These neurons, show a distinctive hyperactivity associated with a membrane depolarization. They are suggested to lead the firing of distant cortical cells during the epileptic discharge.[16]

Another possible initiation pattern tested in rats suggested the thalamocortical (TC) loop is involved in the initiation of spike-and-wave oscillations under certain conditions. In this study, relay and reticular thalamic neurons of epileptic and non-epileptic rats were dual extracellularly recorded and juxtacellularly labeled.[3] Medium oscillations (5–9 Hz) in both types of rats were noted to occur randomly in an unsynchronized pattern in relay and reticular neurons. However, spontaneous spike-and-wave discharges were observed in epileptic rats when the medium oscillations became synchronized, suggesting a dependence of the two. However, since medium ranged oscillations only developed into spike-and-wave discharges spontaneously, genetic factors also seem to contribute to the initiation of synchronized oscillations. These genetic factors may contribute to spike-and-wave oscillations by decreasing the action potential threshold in reticular cells, making them more excitable and potentially easier to initiate synchronized firing.[3] Another study has shown that these medium oscillations have led to spike-and-wave discharges.[17] The activity of the primary and secondary cortical regions, as well as the adjacent insular cortex were recorded using an EEG and where applied with electrical stimulation. The findings here showed that the onset of spike-and-wave discharged were followed by 5–9 Hz oscillations in these cortical regions as well.[17]

Genetic/developmental factors

[edit]

Elongator Protein Complex 4 (ELP4) has been identified as a key component in the transcription of genes known to regulate the actin cytoskeleton, cell motility and migration of neurons. Research on ELP4 has been linked the gene to a centrotemporal sharp spike phenotype. Hypotheses have been made that a mutation in the non-coding region of the ELP4 gene may interfere with elongo-mediated gene interaction, specifically during the developmental stages of the cortical region.[18] This mutation may be responsible for a predisposition to spike-and-wave discharges, as well as other neurodevelopmental disorders.

Another study revealed that glucose may also be relevant to spike-and-wave occurrence in mice that contained a knock-in of the human GABA(A) γ2(R43Q) mutation, which has been known to be a genetic factor involved in the causation of absence epilepsy.[19] These absence seizure prone mice were injected with insulin to lower blood glucose levels by 40%. This reduction in blood glucose led to double the occurrence of spike-and-wave activity. Similar to the insulin effect, overnight fasting, where blood glucose levels were reduced by 35% also showed this double in occurrence. This model concludes that low glucose levels could be a potential trigger for absence seizures, and could be an environmental risk factor for humans.[19]

Spike-and-wave in epilepsy

[edit]

Absence epilepsy

[edit]

Bursts of generalized spike-and-wave discharges lasting two seconds or longer is considered an absence seizure.[20] Absence seizures are generalized epileptic seizures that can be divided into two types, typical and atypical. Typical and atypical absence seizures display two different kinds of spike-and-wave patterns. Typical absence seizures are described by generalized spike-and-wave patterns on an EEG with a discharge of 2.5 Hz or greater. They can be characterized by an increase in synchronization of discharges in the thalamocortical circuitry. They can also be characterized by the acute onset and termination of the seizure. Atypical absence seizures have a higher frequency in children with severe epilepsy that suffer from multiple types of seizures. The spike-and-wave pattern seen here is more irregular than the generalized pattern and also seems to be slower. This irregular pattern is due to non-synchronous discharges of the thalamocortical circuitry. The onset and termination in these atypical absence seizures seem to be less acute than the typical absence seizures.[21]

Lennox-Gastaut syndrome

[edit]

Epileptic encephalopathies are a group of conditions that result in deterioration of sensory, cognitive, and motor functions due to consistent epileptic activity. Lennox-Gastaut syndrome (LGS) is a childhood epileptic encephalopathy characterized with generalized seizures and slow spike-wave activity while awake. LGS is a combination of atonic absences, tonic seizures, cognitive deterioration, and slow spike-wave activity in the EEG. This syndrome usually results from focal, multifocal, or diffuse brain damage and can be divided into symptomatic and cryptogenic types. Cognitive deterioration with high-frequency spike-wave activity affects most patients 2–9 years old with generalized seizures. The age of onset for LGS is between 1 and 10 years, between 2 and 6 years for symptomatic cases and 5 and 8 years for cryptogenic cases. Episodes can be triggered by modifications of treatment, which usually involves benzodiazepines, or changes in the conditions of life.[22]

Ohtahara syndrome

[edit]

Ohtahara syndrome (OS), also known as early infantile epileptic encephalopathy (EIEE) with suppression-burst (S-B), is the most severe and the earliest-developing epileptic encephalopathy in children. This syndrome is characterized on an EEG by high voltage bursts and slow waves mixed with multifocal spikes alternating with almost flat suppression phases. The S-B will gradually begin to taper away at 3 months and disappear by 6 months. OS will transition to West syndrome or LGS with age. Tonic spasms are the main seizures observed in OS. Unlike LGS, the spike-and-wave pattern is consistent during both waking and sleeping states.[23] Symptoms of OS include:[24]

  • Genetic defects
  • Mitochondrial disease
    • Mitochondrial respiratory chain defects
  • Inborn errors of metabolism
    • Glycine encephalopathy
  • Cortical malformations
  • Frequent minor generalized seizures
  • Severe and continuous epileptic EEG abnormality
  • Severe psychomotor prognosis

Spike-and-wave pattern during sleep

[edit]

In continuous spike-and-wave syndrome (CSWS), a rare form of age-related epilepsy, children between the ages of three and seven exhibit continuous spike-and-wave discharges during slow-sleep. This rare disorder is also called encephalopathy with status epilepticus during sleep (ESES) and found in 0.2–0.5% of all child epilepsy cases. Discharges rarely result in absence seizures, but motor impairment and neurophysiological regression have been found in CSWS. Spike-and-wave activity occupies about 85% of the non-rapid eye movement sleep.[25] This continuous pattern during sleep, like other aspects of spike-and-wave activity, are not completely understood either. However, what is hypothesized is that corticothalamic neuronal network that is involved in oscillating sleep patterns may begin to function as a pathologic discharging source.[18]

Clinical relevance

[edit]

Reoccurrence after a solitary unprovoked seizure in children is about 50%, so the use of anti-epileptic drugs (AEDs) is very prevalent. AEDs aim to slow down the excess firing, associated with spike-and-wave discharges, at the beginning of seizures. They can bring about serious adverse drug reactions so physicians need to be aware of the safety and admissibility for each drug. These adverse effects are a major source of disability, morbidity, and mortality. Some of the adverse effects, such as serious cutaneous, haematological and hepatic events, usually require withdrawal in children and place a heavy burden on the costs of healthcare.[26]

Bromide was introduced as the first anti-epileptic drug 150 years ago. Because of the adverse effects mentioned above, bromide is not currently in use as an AED. Early treatment discontinuation was occurring far too frequently and eventually resulted in negative effects on several patients. Current treatment options include phenytoin, valproic acid, ethosuximide, and the new anti-epileptic drugs. Over the past 20 years, 15 new anti-epileptic drugs with positive outcomes have been introduced to the public. These new AEDs are aimed at improving the cost-benefit balance in AED therapy, improving tolerability profiles and reducing potential for drug interaction.[27] Despite these major advances, there is always room for improvement, especially regarding the tailored treatment of individuals who have suffered adverse effects from older AEDs.[26][28]

References

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Spike-and-wave

View on Grokipedia
from Grokipedia
Spike-and-wave refers to a hallmark electroencephalographic (EEG) pattern in epilepsy, characterized by bilateral, synchronous, and symmetrical generalized epileptiform discharges consisting of a brief spike (typically 25–50 µV amplitude and 10 ms duration) followed by a dome-shaped slow wave (150–200 ms duration), most commonly occurring at a frequency of 3 Hz. This pattern is a defining feature of genetic generalized epilepsy (GGE) syndromes, such as childhood absence epilepsy (CAE), juvenile absence epilepsy (JAE), and juvenile myoclonic epilepsy (JME). The morphology and of spike-and-wave discharges show maximum over frontocentral regions, often involving frontal and midline electrodes, with rhythmic regularity in about 40% of cases, though irregularity is common. Variations include polyspike-and-wave complexes at 4-6 Hz, featuring multiple spikes followed by a slow wave, which are characteristic of JME and often described as atypical generalized spike-and-wave due to non-classic features such as irregular morphology or frequency variation from the standard 3 Hz pattern. This differs from the classic regular 3 Hz spike-and-wave of childhood absence epilepsy and the slow (1-2.5 Hz) atypical spike-and-wave of Lennox-Gastaut syndrome. Additionally, atypical features like focal onset occur in 13.1% of GGE patients. These discharges are often provoked by activation procedures such as or , with 67% occurring during non-rapid eye movement (NREM) . Clinically, spike-and-wave patterns are essential for diagnosing GGE and distinguishing syndromes: 3 Hz discharges are typical of CAE and JAE, correlating with absence seizures involving brief lapses in consciousness without major motor activity, while polyspike-and-wave patterns at 4-6 Hz align with myoclonic, absence, or generalized tonic-clonic seizures in JME. Their presence guides treatment decisions, such as antiepileptic drugs targeting generalized seizures, and underscores the risk of misdiagnosis as focal if features are overlooked, potentially delaying effective management.

Definition and Characteristics

EEG Morphology

The classic spike-and-wave complex in EEG recordings is characterized by a sharp spike component with a duration of 20-80 ms, immediately followed by a slow wave component lasting 200-400 ms, with the entire complex repeating at a frequency of 2.5-3.5 Hz. This rhythmic pattern forms the hallmark of generalized epileptiform activity, typically appearing as high-amplitude discharges that are easily identifiable on standard scalp EEG tracings. Variations of the spike-and-wave pattern include polyspike-and-wave complexes, which feature multiple spikes (typically 2-5) preceding each slow wave and occur at frequencies greater than 3 Hz, often 3.5-6 Hz. "Atypical generalized spike-and-wave" at 4 Hz on EEG typically refers to generalized epileptiform discharges with non-classic features (e.g., irregular morphology or frequency variation from the standard 3 Hz pattern). This pattern at 4 Hz is commonly associated with idiopathic generalized epilepsies, particularly juvenile myoclonic epilepsy (JME), where polyspike-and-wave discharges at 4-6 Hz are characteristic and linked to myoclonic, absence, or generalized tonic-clonic seizures. It differs from the classic regular 3 Hz spike-and-wave of childhood absence epilepsy and the slow (1-2.5 Hz) atypical spike-and-wave of Lennox-Gastaut syndrome. Atypical spike-and-wave patterns, in contrast, exhibit slower frequencies below 2.5 Hz (usually 1-2.5 Hz) and irregular morphology, with less consistent spike-wave coupling and potential asymmetry in amplitude or phase. These discharges display a generalized, synchronous, and bilateral distribution across the , with maximum amplitude often in the frontocentral regions (e.g., electrodes Fz, Cz), and typical surface amplitudes ranging from 100-300 μV. Unlike focal spikes, which are unilateral and may show phase reversal at a specific locus, spike-and-wave patterns are distinguished by their symmetrical bilateral synchrony and absence of or . The spike-and-wave complex was first described in human EEG recordings by Gibbs, Davis, and Lennox in 1935, who identified the 3 Hz pattern in association with petit mal epilepsy. These EEG features are frequently linked to brief behavioral arrests in absence seizures.

Clinical Presentation

Spike-and-wave discharges are most commonly associated with absence seizures, which manifest as sudden, brief episodes of impaired in affected individuals. Typical absence seizures begin abruptly without warning or , characterized by a sudden cessation of ongoing activity, staring blankly ahead, and unresponsiveness to external stimuli, often lasting 5 to 10 seconds. Subtle automatisms, such as eyelid fluttering, lip smacking, or minor hand movements, may accompany these episodes, but there is no significant motor involvement or postictal confusion upon resolution, allowing immediate resumption of normal activity. These seizures frequently occur multiple times per day and can be reliably provoked by during clinical evaluation. In atypical presentations linked to spike-and-wave activity, seizures exhibit less abrupt onsets and offsets, with durations extending to 10 to 30 seconds or longer. These episodes involve variable degrees of impairment, often with subtle motor components such as myoclonic jerks, tonic posturing, or atonic drops, distinguishing them from the more stereotyped typical absences. Responsiveness may be partially preserved, allowing minor reactions to stimuli, though awareness remains significantly reduced. The clinical manifestations directly correlate with the duration of spike-and-wave discharges, during which loss of awareness is consistent and proportional to the electrographic event, without preceding sensory or phenomena. Such presentations are predominantly observed in children aged 4 to 14 years, though they may persist or evolve in some cases.

Historical Background

Early Discoveries

The discovery of the spike-and-wave pattern in (EEG) built upon foundational advancements in recording human brain electrical activity during the early 20th century. In 1924, German psychiatrist recorded the first human EEGs, demonstrating rhythmic brain waves that varied with mental states and laying the groundwork for identifying pathological patterns in conditions like . Berger's work, published in 1929, introduced key rhythms such as the (8-13 Hz), which provided a baseline for distinguishing normal from abnormal EEG activity. A pivotal advancement occurred in 1935 when Frederic A. Gibbs, Hallowell Davis, and William G. Lennox reported the first clear description of the characteristic 3 Hz spike-and-wave discharge associated with absence seizures, then termed petit mal epilepsy. In their study, published in the Archives of Neurology and Psychiatry, the researchers analyzed EEGs from patients experiencing brief lapses of , observing synchronized, bilateral spike-and-wave complexes occurring at approximately three per second during seizures. This pattern was distinctly different from previously identified rhythms, such as Berger's , due to its higher amplitude, sharper morphology, and direct correlation with clinical impairment. The 1935 findings highlighted the utility of EEG in , with the spike-and-wave pattern emerging as a hallmark of petit mal, enabling precise correlation between electrophysiological events and clinical symptoms. Initial observations confirmed the rhythm's consistency across affected individuals, marking a shift toward objective identification of . Subsequent refinements, including animal models in later decades, further elucidated the pattern's mechanisms.

of Research

Following the initial descriptions of spike-and-wave discharges in human EEG recordings, research in the 1950s and 1960s advanced toward theories of their subcortical origins. Herbert Jasper and proposed the "centrencephalic" hypothesis in 1954, positing a subcortical pacemaker in the midline that diffusely projects to bilateral cortex to produce generalized 3-Hz spike-wave patterns. This built on earlier experiments by Jasper and colleagues, who demonstrated in 1947 that electrical stimulation of the in cats elicited bilaterally synchronous spike-wave discharges resembling absence seizures. By the late 1960s, Pierre Gloor's "corticoreticular" theory refined these ideas, emphasizing interactions between thalamocortical and reticular influences in generating the discharges. These frameworks, developed through studies in animal models during the 1950s-1970s, shifted understanding from purely cortical to integrated network origins. The 1980s and 1990s introduced genetic rodent models for studying spike-and-wave discharges. The Genetic Absence Epilepsy Rat from (GAERS), developed in 1982 through selective of Wistar rats, provided a model for spontaneous absence-like seizures. Similarly, the WAG/Rij rat strain, established in 1986, displayed discharges analogous to human absence epilepsy. From the onward, research has explored ionic and network mechanisms, with studies identifying roles for calcium channels in thalamocortical essential for rhythmic oscillations. Investigations into metabotropic glutamate receptors, such as mGlu4, have suggested modulation of spike-wave generation in thalamocortical circuits. These models have supported evaluation of antiepileptic drugs targeting generalized seizures. Post-2020 research has utilized advanced and circuit techniques to map spike-wave networks, incorporating fMRI-EEG correlations and optogenetic manipulations in models to examine thalamocortical dynamics. These approaches continue to inform historical theories while addressing gaps in therapeutic translation.

Pathophysiological Mechanisms

Thalamocortical Circuits

Spike-and-wave discharges arise from oscillatory interactions within thalamocortical circuits, involving reciprocal connections between thalamic relay nuclei, such as the ventrolateral nucleus, and layer IV of the . These loops generate synchronized rhythms where the "spike" component results from depolarizing bursts in thalamic neurons, primarily driven by calcium (Ca²⁺) channels that enable low-threshold spiking. The subsequent "wave" phase involves inhibition, leading to hyperpolarization that resets the circuit for the next cycle. This mechanism was elucidated in foundational studies using feline models, demonstrating how these circuits produce the characteristic 3 Hz bilaterally synchronous pattern observed in absence epilepsy. Initiation of these discharges begins with low-threshold spikes in thalamic relay neurons, which trigger burst firing upon deinactivation of Ca²⁺ channels during hyperpolarized states. Cortical feedback then amplifies this activity, entraining neocortical pyramidal cells and propagating the oscillation at approximately 3 Hz through excitatory projections. The reticular thalamic nucleus (nRt) plays a crucial role in synchronizing these bursts via inhibition of relay cells, creating a feedback loop that sustains the rhythm across hemispheres. Disruptions in this balance, such as increased thalamic hyperexcitability, underlie epileptic manifestations by lowering the threshold for oscillation onset. Animal models provide key evidence for the core of these circuits; decortication experiments in cats reveal that spike-and-wave-like activity persists in isolated , indicating that cortical involvement amplifies but does not solely generate the discharge. Genetic predispositions can enhance vulnerability in these circuits by altering channel kinetics, though the primary dynamics remain rooted in the electrophysiological properties described.

Genetic and Developmental Influences

Spike-and-wave discharges, characteristic of certain epileptic syndromes, exhibit significant genetic influences, with familial clustering observed in 20% to 40% of cases of childhood absence epilepsy (CAE), the primary syndrome associated with this EEG pattern. This clustering underscores a hereditary component, where first-degree relatives often share similar phenotypes. Key genetic contributors include mutations in the CACNA1H gene, which encodes calcium channels critical for thalamic burst firing; nonsynonymous single nucleotide polymorphisms in CACNA1H have been identified exclusively in CAE patients, enhancing susceptibility to absence seizures. The R43Q in the GABRG2 subunit of the GABA(A) receptor, an autosomal dominant variant, is strongly linked to CAE and febrile seizures, leading to receptor retention in the and impaired inhibitory . Beyond monogenic effects, polygenic risk plays a central role, with genome-wide association studies (GWAS) post-2020 identifying over 10 loci associated with , including absence subtypes, through meta-analyses of large cohorts. These polygenic contributions highlight a complex pattern rather than single-gene dominance. Animal models, such as knock-in mice for the GABRG2 R43Q , confirm by recapitulating spike-and-wave discharges and absence-like behaviors, demonstrating how these variants disrupt thalamocortical oscillations. Developmentally, spike-and-wave susceptibility peaks during childhood due to thalamocortical circuit maturation, with CAE onset typically between ages 4 and 8 years, coinciding with and network stabilization in thalamic and cortical regions. This maturational window renders the brain vulnerable to oscillatory disruptions, as immature connections facilitate the rhythmic synchronization underlying absence s. By , many cases regress as these networks mature further and inhibitory mechanisms strengthen, leading to remission in up to 70% of CAE patients.

Associations with Epileptic Syndromes

Childhood Absence Epilepsy

Childhood absence epilepsy (CAE) is a common syndrome characterized by recurrent absence seizures, where the hallmark electroencephalographic (EEG) feature is bilateral synchronous 3 Hz spike-and-wave discharges. These discharges typically exhibit abrupt onset and offset, correlating precisely with the clinical seizure, and are often provoked by during EEG recording in over 90% of cases. The syndrome primarily affects otherwise healthy children, with spike-and-wave patterns reflecting underlying thalamocortical network oscillations as described in broader pathophysiological models. CAE accounts for 10-15% of all childhood epilepsies, with an onset typically between 4 and 8 years of age. Seizures are frequent, occurring multiple times daily and potentially reaching 50-100 or more per day in severe cases, manifesting as brief episodes of impaired with minimal motor activity. Approximately 30-40% of individuals with CAE later develop generalized tonic-clonic seizures (GTCS), often emerging after the initial absence seizures. The prognosis for CAE is generally favorable, with about 70% of cases achieving remission by , allowing discontinuation of therapy without recurrence. While the is primarily polygenic, autosomal dominant inheritance patterns have been identified in some families.

Lennox-Gastaut Syndrome

Lennox-Gastaut syndrome (LGS) is a severe form of childhood characterized by multiple seizure types and developmental delays, where atypical spike-and-wave discharges play a central role in the electroencephalographic (EEG) profile. This syndrome accounts for 1-4% of all childhood epilepsies, with onset typically occurring between 1 and 7 years of age. In many cases, LGS arises following brain injury, such as perinatal hypoxia, infections, or trauma, which contribute to the underlying neurological damage. The hallmark EEG pattern in LGS features atypical spike-and-wave complexes that are slow, with frequencies less than 2.5 Hz, and often irregular or asymmetric, sometimes incorporating multifocal elements across both hemispheres. These discharges are prominently associated with atypical absence, tonic, atonic, and tonic-clonic seizures, which manifest as sudden drops, stiffening, or generalized convulsions, contributing to the syndrome's nature. Interictally, slow spike-and-wave activity appears in almost all EEG recordings, often amid diffuse background slowing, underscoring its diagnostic significance. The prognosis for LGS remains poor, with intellectual disability developing in approximately 90% of patients, alongside persistent seizures into adulthood and high rates of behavioral challenges. Clinical trials of as an adjunctive therapy have demonstrated meaningful efficacy, achieving around 42% reduction in drop frequency compared to in patients with drug-resistant LGS. These findings highlight CBD's role in mitigating drop seizures and improving , though outcomes vary and long-term seizure control is challenging. The thalamocortical circuits implicated in these atypical discharges are shared with other epileptic syndromes but manifest more chaotically in LGS. , also known as early infantile epileptic encephalopathy, is a rare neonatal characterized by onset within the first three months of life, often in the first two weeks, featuring frequent tonic spasms and a distinctive burst-suppression pattern on EEG consisting of high-amplitude slow waves and polyspikes alternating with near-isoelectric suppression phases. This EEG pattern persists across wakefulness and sleep states and may evolve over months into more fragmented discharges, including generalized slow complexes, particularly as the condition transitions toward West syndrome or other encephalopathies around 2-6 months of age. The syndrome has an estimated prevalence of 1 in 50,000 to 1 in 100,000 live births and is frequently linked to genetic mutations, such as those in the gene, which encodes a protein critical for release and accounts for 10-38% of cases. Recent studies from the 2020s have further implicated KCNQ2 gene mutations, which affect voltage-gated potassium channels and can manifest as the Ohtahara phenotype with refractory seizures and developmental regression. Juvenile absence epilepsy (JAE) is an syndrome similar to CAE but with later onset (typically 10-17 years) and less frequent seizures. It features 3 Hz spike-and-wave discharges on EEG, often with longer duration and polyspike elements compared to CAE, and is associated with absence seizures that may include mild myoclonic or automatism components. Approximately 80% of JAE cases remit by adulthood, though 10-15% may evolve to include tonic-clonic seizures. In (), a common , interictal spike-and-wave discharges are notably enhanced during non-REM , particularly in slow-wave stages, where they appear as generalized 3-6 Hz polyspike-and-wave complexes that increase in frequency compared to . These discharges can fragment or interact with microstructures, such as spindles, reflecting a pathological transformation where normal thalamocortical oscillations are disrupted into epileptiform activity. Persistent epileptiform discharges on EEG are associated with a higher risk of recurrence upon medication withdrawal in .

Diagnostic and Clinical Relevance

Diagnostic Utility

Spike-and-wave discharges on electroencephalography (EEG) serve as a cornerstone for diagnosing generalized epilepsies, particularly those involving absence seizures, by identifying characteristic paroxysmal patterns that correlate with clinical events. Routine EEG protocols incorporate activation procedures to enhance detection, including hyperventilation for up to three minutes and intermittent photic stimulation, which can provoke generalized spike-and-wave discharges in susceptible individuals. Hyperventilation is especially effective, eliciting these discharges in over 90% of patients with childhood absence epilepsy (CAE). For more precise evaluation, prolonged video-EEG monitoring is employed to synchronize EEG findings with behavioral manifestations, confirming the epileptic nature of episodes and distinguishing subtle absences from other transient alterations in awareness. The 3 Hz generalized spike-and-wave pattern is for typical in CAE, appearing bilaterally and symmetrically during ictal events in virtually all affected children, providing high diagnostic specificity. Interictal epileptiform discharges, such as isolated spikes or fragmentary spike-and-wave complexes, further support the diagnosis and carry prognostic value; their presence on an initial EEG following a first unprovoked elevates the risk of recurrence by approximately 2.5- to 3-fold compared to EEGs without such abnormalities. In CAE, this morphology manifests as regular 3 Hz rhythms, contrasting with slower or irregular patterns seen in other syndromes like Lennox-Gastaut syndrome. Differentiation from non-epileptic mimics is critical, as EEG reliably distinguishes true spike-and-wave discharges from psychogenic non-epileptic seizures (PNES), which lack corresponding epileptiform activity during stereotyped behavioral spells. Video-EEG is particularly valuable here, capturing the absence of EEG changes during PNES events despite clinical similarity to absences, thus preventing misdiagnosis. Similarly, generalized spike-and-wave must be differentiated from focal epileptiform discharges, which may propagate but originate unilaterally, often requiring topographic analysis to confirm the bilateral synchrony indicative of . Advancements in quantitative have enhanced diagnostic precision, with source localization techniques applied to high-density EEG data revealing the thalamocortical origins of generalized spike-and-wave discharges. Post-2020 studies utilizing distributed source modeling, such as classical LORETA analogs, demonstrate that these patterns localize primarily to frontal and thalamic regions during absence seizures, aiding in classification and excluding focal generators. Such methods improve sensitivity for subtle or subclinical discharges, supporting earlier and more accurate in ambiguous cases.

Prognostic and Therapeutic Aspects

The of spike-and-wave discharges varies significantly depending on the associated epileptic syndrome. In childhood absence (CAE), outcomes are generally favorable, with remission rates ranging from 60% to 90% following treatment, often achieved within 3 to 8 years of onset. In contrast, Lennox-Gastaut syndrome (LGS) carries a poorer , with fewer than 10% of patients achieving long-term freedom and more than 90% remaining to multiple therapies into adulthood. Persistence or activation of spike-and-wave discharges during serves as a key marker for potential relapse or in absence epilepsies, guiding ongoing monitoring after apparent remission. Standard treatments for spike-and-wave associated with typical absence s in CAE target the underlying oscillatory mechanisms, primarily through blockade of calcium channels in thalamocortical neurons, which disrupts the generation of 3 Hz spike-and-wave complexes. and are first-line agents, achieving freedom in approximately 45% of cases at 12 months, with preferred due to its favorable side-effect profile for absence-only presentations. For atypical absence s, as seen in LGS, is commonly used as an adjunctive therapy, providing greater than 50% reduction in about 47% of patients when combined with other agents. Since 2000, over 15 new antiepileptic drugs (AEDs), including , topiramate, , and , have expanded options, though their efficacy against absence s remains variable and often secondary to broader-spectrum activity. Emerging therapies post-2020 focus on syndromes with spike-and-wave overlaps, such as and developmental epileptic encephalopathies with spike-wave activation in sleep (DEE-SWAS). , approved for Dravet and LGS, has shown promise in reducing frequency and spike-wave index in DEE-SWAS cases, with exploratory studies reporting significant improvements in both seizures and neurocognitive outcomes at low doses (0.4-0.7 mg/kg/day). Preclinical therapies targeting monogenic causes of genetic epilepsies with spike-and-wave features, such as SCN2A mutations, have shown promise in alleviating absence epilepsy in mouse models as of 2025. Additionally, as of 2025, relutrigine has received FDA Designation for treating seizures associated with SCN2A and SCN8A developmental and epileptic encephalopathies. Precision medicine approaches, including genetic subtyping to guide repurposed drugs like for specific channelopathies, are gaining traction, with 2025 reviews highlighting their potential to improve outcomes in drug-resistant cases beyond traditional AEDs.

References

  1. https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2017.00499/full
  2. https://www.nejm.org/doi/full/10.1056/NEJMra022308
  3. https://www.ncbi.nlm.nih.gov/books/NBK537109/
  4. https://www.ncbi.nlm.nih.gov/books/NBK532965/
  5. https://www.ncbi.nlm.nih.gov/books/NBK557655/
  6. https://www.sciencedirect.com/topics/neuroscience/spike-and-wave
  7. https://pmc.ncbi.nlm.nih.gov/articles/PMC3955533/
  8. https://www.sciencedirect.com/science/article/pii/S2467981X21000263
  9. https://jamanetwork.com/journals/archneurpsyc/fullarticle/646995
  10. https://emedicine.medscape.com/article/1140724-overview
  11. https://www.ncbi.nlm.nih.gov/books/NBK499867/
  12. https://pmc.ncbi.nlm.nih.gov/articles/PMC6394437/
  13. https://pmc.ncbi.nlm.nih.gov/articles/PMC8255168/
  14. https://pmc.ncbi.nlm.nih.gov/articles/PMC3697883/
  15. https://www.epilepsy.com/what-is-epilepsy/seizure-types/atypical-absence-seizures
  16. https://pmc.ncbi.nlm.nih.gov/articles/PMC324577/
  17. https://pmc.ncbi.nlm.nih.gov/articles/PMC11212660/
  18. https://jnnp.bmj.com/content/74/1/9
  19. https://jamanetwork.com/journals/archneurpsyc/article-abstract/549281
  20. https://pmc.ncbi.nlm.nih.gov/articles/PMC4878899/
  21. https://jamanetwork.com/journals/jamaneurology/fullarticle/787921
  22. https://www.researchgate.net/publication/278040147_The_Genetic_Absence_Epilepsy_Rat_from_Strasbourg_as_a_model_to_decipher_the_neuronal_and_network_mechanisms_of_generalized_idiopathic_epilepsies
  23. https://doi.org/10.1111/j.1528-1167.2012.03421.x
  24. https://www.jneurosci.org/content/24/22/5249
  25. https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1528-1167.2011.03082.x
  26. https://pmc.ncbi.nlm.nih.gov/articles/PMC3716601/
  27. https://link.springer.com/article/10.1007/s13311-021-01049-y
  28. https://pubmed.ncbi.nlm.nih.gov/35875425/
  29. https://www.sciencedirect.com/science/article/pii/S0969996123002498
  30. https://www.medlink.com/articles/childhood-absence-epilepsy
  31. https://www.sciencedirect.com/science/article/pii/S1059131113000630
  32. https://pubmed.ncbi.nlm.nih.gov/16116110/
  33. https://pmc.ncbi.nlm.nih.gov/articles/PMC1464161/
  34. https://pmc.ncbi.nlm.nih.gov/articles/PMC6729953/
  35. https://www.nature.com/articles/s41588-023-01485-w
  36. https://www.ncbi.nlm.nih.gov/books/NBK98202/
  37. https://emedicine.medscape.com/article/1183858-overview
  38. https://www.childneurologyfoundation.org/disorder/absence-epilepsy/
  39. https://pubmed.ncbi.nlm.nih.gov/39175400/
  40. https://publications.aap.org/pediatriccare/article/doi/10.1542/aap.ppcqr.396225/95/Seizure-Disorders
  41. https://omim.org/entry/600131
  42. https://www.orpha.net/en/disease/detail/64280
  43. https://emedicine.medscape.com/article/1176735-overview
  44. https://www.rarediseaseadvisor.com/disease-info-pages/lennox-gastaut-syndrome-etiology/
  45. https://www.epilepsydiagnosis.org/syndrome/lgs-eeg.html
  46. http://www.eegpedia.org/index.php?title=Lennox_Gastaut_Syndrome
  47. https://www.epilepsy.com/what-is-epilepsy/syndromes/lennox-gastaut-syndrome
  48. https://www.sciencedirect.com/science/article/abs/pii/S0920121124001219
  49. https://www.childneurologyfoundation.org/disorder/lennox-gastaut-syndrome/
  50. https://www.nejm.org/doi/full/10.1056/NEJMoa1714631
  51. https://www.lgsfoundation.org/about-lgs-2/what-is-lennox-gastaut-syndrome/
  52. https://www.sciencedirect.com/topics/medicine-and-dentistry/ohtahara-syndrome
  53. https://pubmed.ncbi.nlm.nih.gov/11751020/
  54. https://pubmed.ncbi.nlm.nih.gov/23019763/
  55. https://www.orpha.net/en/disease/detail/1934
  56. https://www.epilepsy.com/what-is-epilepsy/syndromes/early-infantile-developmental-epileptic-encephalopathy
  57. https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2014.00136/full
  58. https://www.researchgate.net/publication/392268745_KCNQ2_pathogenic_variants_in_early-infantile_developmental_and_epileptic_encephalopathy_in_Indonesia
  59. https://www.ncbi.nlm.nih.gov/books/NBK559175/
  60. https://www.epilepsy.com/what-is-epilepsy/syndromes/juvenile-absence-epilepsy
  61. https://www.sciencedirect.com/science/article/pii/S1059131124001535
  62. https://www.epilepsy.com/what-is-epilepsy/syndromes/juvenile-myoclonic-epilepsy
  63. https://www.sciencedirect.com/science/article/abs/pii/S0887899406005765
  64. https://www.eneuro.org/content/7/1/ENEURO.0253-19.2019
  65. https://pmc.ncbi.nlm.nih.gov/articles/PMC8251928/
  66. https://epilepsysociety.org.uk/sites/default/files/2020-08/Chapter20SmithKennett2015.pdf
  67. https://journals.sagepub.com/doi/10.1177/08830738241273347
  68. https://pmc.ncbi.nlm.nih.gov/articles/PMC10563901/
  69. https://www.epilepsy.com/what-is-epilepsy/syndromes/childhood-absence-epilepsy
  70. https://onlinelibrary.wiley.com/doi/10.1111/epi.18591
  71. https://www.epilepsydiagnosis.org/seizure/absence-typical-eeg.html
  72. https://www.sciencedirect.com/science/article/pii/S1059131111002408
  73. https://pmc.ncbi.nlm.nih.gov/articles/PMC3992252/
  74. https://link.springer.com/article/10.1007/s10309-022-00469-w
  75. https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2022.831546/full
  76. https://pmc.ncbi.nlm.nih.gov/articles/PMC12014921/
  77. https://www.mdpi.com/2227-9067/9/10/1452
  78. https://pmc.ncbi.nlm.nih.gov/articles/PMC5404809/
  79. https://turkjpediatr.org/article/download/1581/1563/1563
  80. https://pmc.ncbi.nlm.nih.gov/articles/PMC6464603/
  81. https://adc.bmj.com/content/95/8/599
  82. https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2017.00505/full
  83. https://pmc.ncbi.nlm.nih.gov/articles/PMC4110862/
  84. https://www.sciencedirect.com/science/article/abs/pii/S0920121125001883
  85. https://www.biorxiv.org/content/10.1101/2025.06.03.657652v1.full-text
  86. https://www.neurologylive.com/view/breakthrough-therapy-designation-granted-relutrigine-scn2a-scn8a-developmental-epileptic-encephalopathies
  87. https://onlinelibrary.wiley.com/doi/10.1002/epi4.70065?af=R
Add your contribution
Related Hubs
User Avatar
No comments yet.